The Clorox Company (CLX)

Investment Committee Summary

Investment Thesis

At $84.35 (13 October 2026) Clorox trades on roughly 15x forward earnings for a portfolio the market treats as ex-growth, with a dividend yield high enough to signal doubt about payout durability against net debt of ~$3.3B. The engine's view is more balanced than the headline multiple but it is not constructive. Probability-weighted value is $93.03 and the twelve-month target $91.28, while the blend triangulates to $83.54 — a gap of -1% that leaves the shares fairly valued against the anchor set and produces HOLD. The anchors themselves disagree sharply: the cash-flow read on a conservative terminal multiple is the lowest in the set, the terminal-growth variant is materially higher, and peer cross-reads higher again. That dispersion is a warning about anchor reliability, not a menu to choose from, and it is why this is a valuation call rather than a contrarian value trade. An operating margin of 25% (reported GAAP, TTM to Jun 2026) is respectable but is being defended with price rather than volume. The single most damaging risk is private-label substitution compressing earnings and the multiple together — the structural scenario that puts the target below the 52-week low.

Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.

The dashboard below is the whole argument on one page: spot ($84.35) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Anti-Thesis (The Real Bear Case)

The structural bear has a coherent mechanism. Clorox's core categories — bleach, trash bags, wipes, charcoal — are functionally commoditised; private label matches performance at a visible shelf-price discount, and retailers have every incentive to push it as consumers trade down. Post-inflation pricing rebuilt margin but shed volume, and once the pricing lever is exhausted the arithmetic turns: negative volume, mix erosion and promotional reinvestment push the operating margin well below 25% (reported GAAP, TTM to Jun 2026) while revenue contracts outright. With net debt of ~$3.3B and a dividend consuming most of free cash flow, the balance sheet offers no offset and the payout becomes the adjustment variable rather than the support. Earnings and the multiple de-rate together from 15x, which is how the structural target lands below the 52-week low.

Key Debate

Gross Margin explains 58% of Monte Carlo outcome variance — the single variable that decides which side is right.

What the Market Is Pricing In

At the current price, the market pays 14.6× consensus forward EPS, vs the house DCF terminal 14.0×, and a peer median 23.6×. The house DCF sits 22% below spot, so the market is pricing in more than the house case — roughly 1.8pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.

Scenario Analysis

The scenario tree spans a structural 'Structural — Private-Label / Brand Erosion' downside ($43.70) to a 'Bull — Defensive Re-Rate' bull case ($150); the probability-weighted blend (PWEV $93.03) is +10% versus spot.

SBC charge: scenario targets are gross per-share prices; the PWEV is reduced by one year of stock-based-compensation dilution (1.5% of shares, on SBC ≈ 1% of revenue), trimming the gross PWEV of $94.42 to $93.03 (-1.5%). SBC is charged once, as dilution — never also deducted from FCF.

Scenario rationale — the driver path behind every target:

• Structural — Private-Label / Brand Erosion (20%, $43.70). Structural impairment — private-label / brand erosion: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
• Consumer / Input Recession (18%, $77.70). Cyclical downturn — branded HPC pricing power + organic volume + input costs (beauty: China/travel-retail) weakens for 1–2 years before normalising.
• Base — Pricing-Led Organic Growth (34%, $101). Mid-cycle — normalised branded HPC pricing power + organic volume + input costs (beauty: China/travel-retail); disciplined capital allocation; steady returns.
• Growth — Premium Innovation + EM (20%, $127). Upside — premium innovation + emerging markets lifts earnings above mid-cycle; the multiple expands modestly.
• Bull — Defensive Re-Rate (8%, $150). Upside tail — sustained tight conditions or a structural re-rate on premium innovation + emerging markets.

Valuation Triangulation

Four weighted anchors — an intrinsic dcf, a scenario-weighted pwev, a monte carlo median (student-t + regime switching) and a peer p/e re-rate — read them with their basis in mind. The Monte Carlo, the scenario PWEV, any DCF's exit-multiple terminal and any peer re-rate key off a market multiple, so they are not independent; only a DCF's explicit-period cash flows are multiple-free, and its terminal usually carries most of its value. The discipline is to read the spread, not to treat four numbers as four independent votes.

The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts is not computed, so 15% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way. The company-lever row in the Sensitivity section is an illustrative EBIT × multiple value, not a sum-of-parts anchor.

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

Monte Carlo — the outcome distribution

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $81.92 and 48% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (58% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.

DCF — explicit-period cash flows with an exit-multiple terminal

A 5-year cash-flow path discounted at a WACC of 7.5%, plus a terminal value of final-year FCF × 14.0x — a terminal multiple equal to 0.85 × the base multiple that the Monte Carlo and the scenario tree also use → $65.74. The terminal value is 72% of enterprise value, so this anchor moves with the multiple assumption. The heaviest anchor in this blend (42%); because its terminal is a market multiple, it is not independent of the multiple-driven anchors.

Peer benchmarking — relative value

Against its 3 peers in the same GICS sub-industry, re-rating to their median forward multiple (P/E 23.6x) implies $137. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 9% so market sentiment does not set the fair value.

Across all anchors the spread is 129% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Sensitivity

DCF/share — WACC × terminal multiple

DCF/share — revenue CAGR Δ × model op-margin Δ (Δ applied to the DCF's house margin path)

Tornado — DCF/share swing by driver (widest first)

Company lever — value at the base multiple vs Household & Personal Care multiple (base 15.0x)

Illustrative: segment EBIT × multiple, plus net cash, over basic shares — it does not enter the triangulated fair value.

Peer Quality & Weighting

Quality-weighted forward P/E: 17.8× (simple median 23.6×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $79.12–$129, centre $101 (+20% vs spot); spot sits at the 11th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

That ratio is (triangulated FV ÷ price − 1) ÷ (1 − 'Structural — Private-Label / Brand Erosion' target ÷ price). 'Structural — Private-Label / Brand Erosion' ($43.70, probability 20%) is the lowest-target scenario in the tree, taken gross of SBC dilution. With a leg missing the ratio is withheld rather than computed from a magnitude. Bull case (Bull — Defensive Re-Rate): $150.

Company Overview & Business Model

The Clorox Company — CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS. The Clorox Company, based in Oakland, California, is an American global manufacturer and marketer of consumer and professional products.

Company description as supplied by Alpha Vantage; not checked against the company's filings.

How it makes money.

† Model margin = gross margin − the opex ratio calibrated so the Monte Carlo median EPS meets the EPS target; it is not a reported operating margin.

Reported operating margin (GAAP): 24.7% for the fiscal year ended 2026-06-30; 24.7% TTM to 2026-06-30 (Alpha Vantage INCOME_STATEMENT).

Edge. Narrow moat — Clorox has a narrow moat from #1/#2 U.S. share in cleaning/bleach, trash bags (Glad), charcoal (Kingsford) and Burt's Bees - strong domestic brands but a smaller, less-international, more-concentrated portfolio than CL/CHD. The falsifiable test is category volume defence post-pandemic normalisation and after the ERP/cyber disruption; if volumes stay ex-growth and net debt caps reinvestment, the ~15x forward multiple is appropriate and should not re-rate toward the ~23x peer level.

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

For comparison, the company's reported GAAP operating margin was 24.7% for the fiscal year ended 2026-06-30; 24.7% TTM to 2026-06-30 (Alpha Vantage INCOME_STATEMENT).

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Capital intensity & shareholder returns (ESTIMATE)

Structural risk vs optionality (INFERENCE)

Balance Sheet & Liquidity

Balance-sheet data as of 2026-06-30 (Alpha Vantage).

Capital Allocation

Free-Cash-Flow Quality

Accounting quality: SBC 1% of revenue; cash conversion (OCF/NI) 102% — cash-backed.

Competitive Moat

Moat sources:

• FACT: #1/#2 U.S. share in cleaning/disinfecting (Clorox bleach/wipes), trash bags (Glad) and charcoal (Kingsford)
• INFERENCE: brand trust in disinfecting (reinforced during the pandemic) supports pricing, though the volume boost has faded
• ABSENCE: limited international scale and a concentrated, mature category set leave less growth runway than CL/CHD
• ABSENCE: $3.3bn net debt constrains the reinvestment/acquisition flywheel that supports peers' moats

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q4): management +0.33 vs analyst floor +0.00 → delta +0.33 (n=34 mgmt / 29 Q&A; 31st pctile across the S&P book, z -0.6).

Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.

News (last 365d, 1419 articles): avg ticker sentiment +0.04 (bullish 15% / bearish 10%)

Consensus & Market Expectations

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Catalyst Calendar

• 2026-11-02 (~21d) — Quarterly earnings — est. EPS $0.99 (AV EARNINGS_CALENDAR)
• 2026-11-03 (~22d) — FQ1 2027 results + gross-margin recovery and dividend coverage (authored)
• 2027-02-01 (~112d) — Portfolio-optimisation / divestiture update (non-core brand pruning) (authored)

Forecast Track Record

• EPS surprise: beat 75% of the last 8 quarters; average surprise +10.2%.

Catalyst Timeline

7 catalysts in the next 90 days (of 15 tracked). Importance 1–3; confidence 0–1.

_Sources: extended.catalysts, data/catalysts/.json, data/catalysts/macro.json, AV DIVIDENDS, opex 3rd-Friday calc.

Regulatory & Legal Risk

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

Decision Rules (Machine-Checked)

Stance: Hold — 0 bullish / 1 bearish / 1 caution rules triggered of 6 evaluable (0 lacked data).

Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is what the model's own rules read on this name; it does not modify the published research rating, and it is not personal financial advice.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

• Organic sales growth (YoY) < 1% (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
• Operating margin (fully loaded) < 13% (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
• Organic volume contribution to sales growth < -2% while price/mix remains positive (2 consecutive prints). Volume declining while pricing holds is the trade-down signature: consumers substituting to private label rather than deferring purchases. It distinguishes structural share loss from a cyclical demand pause.
• US tracked-channel share in core categories (bleach, trash bags, wipes, charcoal) declining measurable share loss in 2 or more of the 4 largest categories (2 consecutive prints). The structural scenario's mechanism is private-label substitution in functionally commoditised categories. Broad-based share loss, not a single-category wobble, confirms the brand premium is eroding.
• Net debt / EBITDA > 3.0x (single event). (rationale withheld pending re-authoring — frozen figure or verdict)

Fact / Inference / Speculation

• FACT: Spot $84.35; 52-week range $79.12–$129; engine rating HOLD; house target $91.28 (+8%). (source: Alpha Vantage 2026-10-12, 13 October 2026)
• INFERENCE: Triangulated FV $83.54 (-1% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the DCF anchor sits below the multiple-discipline core.
• SPECULATION: At current prices the embedded bet is that Gross Margin keeps surprising favourably — an operating call the next two prints will test.

Conviction Score

Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.

47.3/100 (confidence band 34.6–60.0), 13th percentile of 928 covered names (as of 2026-10-12). Weighted composite under config ros-1.21.0 — every component and its inputs below.

Missing inputs (macro tailwinds) are excluded and the remaining weights renormalised; the confidence band widens accordingly.

Score history: 48.5 → 48.6 → 48.5 → 47.6 → 47.8 → 47.7 → 47.6 → 47.5.

Probability-Weighted Return Profile

Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.

The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.

Expected Alpha

Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).

A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.

Probability Cross-Checks

Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.

Authored set: 5 scenarios, probabilities summing to 1.0, mean target $94.42.

Factor Exposures

Cross-sectional percentiles over 928 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.

Market interaction: correlation vs SPY +0.16, vs QQQ +0.05 (trailing ~1y daily returns).

Rating Bridge

Rating = HOLD because:

• Probability-weighted scenario value implies +10% vs spot
• Monte Carlo median implies -3% vs spot
• DCF fair value (exit-multiple terminal) implies -22% vs spot — but this is terminal-value sensitive (exit-multiple $65.74 vs Gordon $96.88, 47% apart), so it carries less weight
• Bear case (Structural — Private-Label / Brand Erosion) downside is -48% vs spot
• Net: the valuation anchor itself sits 1.0% below spot, so there is no reward leg to weigh against the bear case and the reward-to-risk ratio is withheld rather than computed off a negative upside. The rating is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.

Model Appendix

DCF — line items

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 3% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 7.5% · Σ PV(FCF) $3B + PV(terminal) $8B = EV $11B; − net debt $3.3B → equity $8B ÷ diluted shares $0.12B = $65.74/share (exit-multiple terminal).

• Gordon terminal → $96.88/share — a single-point perpetual-growth cross-check at g = 2.5% (one growth rate, not a range; it is not in the blend).
• Incremental ROIC on the forecast capex ≈ 12% vs WACC 7.5% → above WACC — the build is value-creative.

Peer set

Implied prices at the peer medians: same-sub-industry median fwd P/E → $137; EV/Rev → $186.

Weighted fair-value math

Assumption Register

Sensitivity-ranked drivers (widest fair-value swing first): Model op margin ±3pp (42.0); Revenue CAGR ±3pp (24.0); Terminal × ±15% (20.0); WACC ±1pp (8.0); Capex intensity ±15% (8.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Research Provenance

Load-Bearing Assumptions

DCF: WACC 7.5%, terminal multiple 14×, FY+5 revenue $8B. Triangulation leans 42% on DCF, 30% on PWEV, 18% on the Monte Carlo median, 9% on peer-implied value.